The US Food and Drug Administration (FDA) has issued a Class I recall of the electrode component of the EMBLEM S-ICD (Boston Scientific), the iconic subcutaneous implantable cardioverter-defibrillator ...
The US Food and Drug Administration has issued a Class I recall of Boston Scientific’s Emblem S-ICD subcutaneous electrode because of an increased risk of fracture that might prevent the ICD from ...
Boston Scientific is recalling the Emblem S-ICD Subcutaneous Electrode because of increased risk of fractures at a specific point (distal to the proximal sense ring), FDA reported this week. The ...
Background: Implantable cardioverter defibrillator (ICD) leads are subject to technical failures and the impact of the resulting public advisories on patient welfare is unclear. The psychological ...
BOSTON -- A novel small-diameter lead wire had a high level of success for delivery of implantable cardioverter-defibrillator (ICD) shocks and low complications, the LEADR pivotal trial showed. The ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results